Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
SEELQ Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: October 23, 2024
Report Source: 2024 2nd Quarter Report
Seelos Therapeutics Inc. Stock Analysis SEELQ
United States Health Care Nano Cap Report: Seelos Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The company is headquartered in New York City, New York and currently employs 8 full-time employees. The company has filed a voluntary petition under chapter 11 of Title 11 of the United States Code in the United States Bankruptcy Court for the Southern District of New York.
Read More Seelos Therapeutics Inc (SEELQ) Chart
Key Statistics of Seelos Therapeutics Inc (SEELQ)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
1004.00P/E Ratio (TTM)
-52 Week Range
Market Cap
112.40Avg. Volume
724.50Dividend Yield
-Financial Metrics & Statements of Seelos Therapeutics Inc (SEELQ)
FAQ's for Seelos Therapeutics Inc (SEELQ)
- According to Musaffa’s Shariah screening methodology, Seelos Therapeutics Inc (SEELQ) is currently classified as NOT HALAL as of October 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Seelos Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Seelos Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Seelos Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Seelos Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Seelos Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.